Cell-Based Flu Antigen to Be Incorporated in DelSite's Nasal Vaccine Product DelSite is developing a nasal powder vaccine for pandemic avian influenza that combines its proprietary GelVac(TM) vaccine ...
AI-driven research has produced nasal antivirals that block flu and Covid before cell infection, pointing to new prevention ...
The company says it is the first nasal allergy spray approved for children as young as four years old. It is a lower dose formulation of the medication meant for adults.
Workers in protective clothing sit near a locked down area after the detection of new cases of Covid-19 in Shanghai on March 14 - Copyright AFP Hector RETAMAL Workers ...
LONDON--(BUSINESS WIRE)--The global nasal implants market is expected to post a CAGR of close to 6% during the period 2019-2023, according to the latest market research report by Technavio. The ...
Product development activities for SPL7013, repurposed as an antiviral nasal spray, are now well advanced with formulations developed, a manufacturer selected and pilot manufacture undertaken ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback